Skip to content
Browse
LatestWorldBusinessSci & TechEntertainmentSportsHealthGames

Edition

GLGlobalUSUSACACanadaUKUKINIndiaPKPakistanSGSingaporeAUAustralia

Sections

Appearance

AboutSourcesContactPrivacy

Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval

Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.

First reported by CNBC 1 source
Read at CNBC(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. CNBC

    Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval (opens CNBC in a new tab)

    Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.

Something wrong with how we've grouped or summarised this story? Report a problem

More in Business

More